ログイン

RECALLS.

RECALLS.
68問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    Blood drop size in the manual wedge technique; a. 1 to 2 mm in diameter b. 2 to 3 mm in diameter c. 4 to 5 mm in diameter d. 5 to 6 mm in diameter

    b. 2 to 3 mm in diameter

  • 2

    In manual wedge technique, the pusher slide is held securely in the dominant hand at about: a. 15 to 20 degree angle b. 30 to 45 degree angle c. 45 to 50 degree angle d. 50 to 75 degree angle

    b. 30 to 45 degree angle

  • 3

    Counting area for the annual platelet count: a. 0.2 mm2 b. 1 mm2 c. 4 mm2 d. 0.4 mm2

    b. 1 mm2

  • 4

    For manual WBC count, after charging the hemocytometer, place it in a moist chamber for ___ minutes before counting the cells to give them time to settle: a. 5 minutes b. 10 minutes c. 15 minutes d. 30 minutes

    b. 10 minutes

  • 5

    Endomitosis occurs in megakaryocyte ____: a. Proliferation b. c. Maturation

    c. Maturation

  • 6

    Disorder characterized by presence of small platelets: a. Wiskott-Aldrich Syndrome b. May-Hegglin Anomaly c. Alport Syndrome d. Bernard-Soulier Syndrome

    a. Wiskott-Aldrich Syndrome

  • 7

    PDW measures: a. Average volume of platelet b. Average size of platelet c. Variation in platelet size d. Uniformity of platelet size

    d. Uniformity of platelet size

  • 8

    Measurement of MPV values should be based on specimens that are between ______: a. 1 to 4 hours b. 2 to 5 hours c. 3 to 6 hours d. 4 to 8 hours

    a. 1 to 4 hours

  • 9

    After 1 hour, an increase in MPV is expected by how many percent? a. 5% b. 10% c. 15% d. 20%

    d. 20%

  • 10

    INR recommended for patients undergoing treatment of deep venous thrombosis: a. 1-2 b. 2-3 c. 2.5-3.5 d. 3

    b. 2-3

  • 11

    Which of the following has the less risk for thrombosis? I. Geriatrics III. Children II. Neonates IV. Young adults a. I, III b. II, IV c. II, III d. I, IV

    c. II, III

  • 12

    One population of cells within the case; small cells predominant; nuclear shape is regular with an occasional cleft; chromatin pattern is homogenous with scanty cytoplasm and nucleoli are rarely visible: a. L1 b. L2 c. L3 d. L4

    a. L1

  • 13

    A medical technologist collected a sample from a patient, however it was short draw. Which of the following will be the effect on the patient’s haematocrit? a. No effect b. Increased c. Decreased

    c. Decreased

  • 14

    When the haematocrit is higher than normal, as in found in patients with polycythemia, the angle should be ___: a. 20 degree b. 30 degree c. 45 degree d. 50 degree

    a. 20 degree

  • 15

    Solid tumor counterpart of Acute Lymphoblastic Leukemia: a. Lymphoma, poorly differentiated b. Lymphoma, well differentiated c. Reticulum cell sarcoma d. Myeloma

    a. Lymphoma, poorly differentiated

  • 16

    Solid tumor counterpart of Plasma Cell Leukemia: a. Lymphoma, poorly differentiated b. Lymphoma, well differentiated c. Reticulum cell sarcoma d. Myeloma

    d. Myeloma

  • 17

    Examples of acquired coagulopathies: I. Pernicious anemia II. Glanzmann thrombasthenia III. Uremia IV. Bernard-Soulier syndrome a. I, III b. I, IV c. II, III d. II, IV

    a. I, III

  • 18

    ESR result of refrigerated sample not returned to room temperature: a. Decreased b. Increased c. No effect

    b. Increased

  • 19

    Components of heme portion of a hemoglobinmolecule: a. 1 iron and 1 pyrrole ring b. 4 iron and 1 pyrrole ring c. 4 iron and 4 pyrrole ring d. 1 iron and 4 pyrrole ring

    d. 1 iron and 4 pyrrole ring

  • 20

    Peripheral zone: I. Glycocalyx II. Sub-membranous area III. Plasma Membrane a. I only b. I, II c. II, III d. I, II, III

    d. I, II, III

  • 21

    Granules formed throughout the remaining maturation of eosinophils: a. Primary granules b. Secondary granules c. Lipid bodies d. Storage vesicles

    b. Secondary granules

  • 22

    Optical light scatter that correlates with cell volume and with internal complexity: I. Forward Light Scatter II. Forward Low Angle Light Scatter III. Forward High Angle Light Scatter IV. Orthogonal Light Scatter a. I, II b. II, III c. III, IV d. I, IV

    b. II, III

  • 23

    The following conditions are associated with normocytic RBCs, except: a. Aplastic anemia b. Hemolytic Anemia c. IDA d. Myelophthisic Anemia

    c. IDA

  • 24

    Stage of cell cycle that normally takes 4 hours: a. G1 b. S c. G2 d. Mitosis

    c. G2

  • 25

    Abnormal proliferation of both erythroid and granulocytic precursors; may include abnormal megakaryocytic and monocytic proliferations a. M4 b. M5 c. M6 d. M7

    c. M6

  • 26

    M6 is also known as? a. Acute Myelomonocytic Leukemia b. Acute Promyelocytic Leukemia c. Acute Erythroleukemia d. Acute Megakaryocytic Leukemia

    c. Acute Erythroleukemia

  • 27

    Who is regarded as the Father of Genetics? a. Anton van Leeuwenhoek b. Edward Jenner c. Gregor Mendel

    c. Gregor Mendel

  • 28

    Recipient of Nobel Prize for his discovery of the mechanism of antibody diversity: a. George Kohler & Cesar Milstein b. Gerald Edelman & Rodney Porter c. Susumu Tonegawa d. Rosalyn Yallow

    c. Susumu Tonegawa

  • 29

    Class II MHC molecules are recognized by which of the following? a. CD4+ T cells b. CD8+ T cells c. Natural killer cells d. Neutrophils

    a. CD4+ T cells

  • 30

    Anticoagulant used to collect blood samples for Direct Antiglobulin Test: a. Heparin b. EDTA c. Citrate d. Oxalate

    b. EDTA

  • 31

    The mot common cause of transfusion-related sepsis is: a. Whole blood b. Packed red cells c. Platelet concentrates d. Leukocyte concentrates

    c. Platelet concentrates

  • 32

    What should be done if a noticeable clot is found in an RBC unit? a. Issue the unit; the blood will be filtered b. Issue the unit; note the presence of clot on the release form c. Filter the unit in the blood bank before issue d. Do not issue the unit

    d. Do not issue the unit

  • 33

    Which of the following antigens are carried on a component of complement? a. Kx b. Lutheran c. Chido/Rodgers d. Gil

    c. Chido/Rodgers

  • 34

    Why is second infection of dengue considered as more severe than the first one?

    b. Because of the presence of more than one serotype

  • 35

    Antibodies to which of the following viral antigens are usually the first to be detected in HIV infection? a. gp120 b. gp160 c. gp41 d. p24

    d. p24

  • 36

    What test/s is not included in blood screening worldwide? a. HCV and HIV-1 b. HIV-2 c. CMV and HIV-2 d. Malaria

    c. CMV and HIV-2

  • 37

    What g is used to prepare pRBC directly from whole blood? a. 2300g b. 3000g c. 3200g d. 5000g

    d. 5000g

  • 38

    Donor deferral if patient is pregnant but had miscarriage within 4 months? a. Accept b. Defer for 6 weeks c. Defer for 6 months d. Defer for 12 months

    a. Accept

  • 39

    A donor has confessed that he had plasma products transfused because of past dengue infection. What is the deferral period for this situation? a. No deferral b. 12 months c. 1 year d. 6 months

    b. 12 months

  • 40

    Tumor marker for breast cancer with recurrence: a. ER/PR b. CEA c. CA 15-3 and CA 19-9 d. CYFRA

    c. CA 15-3

  • 41

    Which of the following autoantibodies indicates presence of systemic lupus? a. Anti-acetylcholine receptor b. Anti-Smith c. Anti-Scl 70 d. Anti-centromere

    b. Anti-Smith

  • 42

    Lack of CD4 and CD8 is characteristic of which of the following? a. Mature T cells b. Activated T cells c. d. Immature thymocytes

    d. Immature thymocytes

  • 43

    He proved that immunity to cowpox provided protection against smallpox, thus the mechanism of cross immunity: a. Mary Mallon b. Robert Koch c. Edward Jenner d. Edelman and Porter

    c. Edward Jenner

  • 44

    What is the corresponding Wiener nomenclature if the inherited gene is RO? a. Rh0 rh’hr’’ b. Rh0 hr’ hr’’ c. Rh0 hr’ rh’’ d. Rh0 rh’ rh’’

    b. Rh0 hr’ hr’’

  • 45

    What is the corresponding Fisher-Race nomenclature if the inherited gene is RO? a. DCe b. Dce c. DcE d. DCE

    b. Dce

  • 46

    Which blood group does Dolichos biflorus agglutinate? a. A1 b. B c. H d. D

    a. A1

  • 47

    The letter “T” in the acronym TORCH stands for? a. Trichenellosis b. Toxoplasmosis c. Treponema d. Trichiuris

    b. Toxoplasmosis

  • 48

    What is the pH of the skin? a. 5.2 b. 5.6 c. 7.2 d. 6.5

    b. 5.6

  • 49

    What is the minimum weight required if a male donor wants to undergo double RBC apheresis? a. > 110 lbs b. > 130 lbs c. > 150 lbs d. > 170 lbs

    b. > 130 lbs

  • 50

    What is the appropriate blood component to be given if a patient has Factor VIII deficiency? a. Washed RBC b. Fresh Frozen Plasma c. Cryoprecipitate d. Platelet concentrate

    c. Cryoprecipitate

  • 51

    What is the most common Lewis phenotype? a. Le (a-b-) b. Le (a+b-) c. Le (a-b+) d. Le (a+b+)

    c. Le (a-b+)

  • 52

    Most common blood group associated with severe delayed HTR: a. ABO b. Rh c. Lewis d. Kidd

    d. Kidd

  • 53

    Which of the following is a professional subject? a. Clinical Chemistry b. Physiology c. Biochemistry d. Anatomy

    a. Clinical Chemistry

  • 54

    All of the following are major subjects, except: a. Clinical Chemistry b. Clinical Microscopy c. Hematology d. Microbiology

    b. Clinical Microscopy

  • 55

    How many times can a person take the licensure exam before taking up refresher course? a. 1 b. 2 c. 3 d. 4

    c. 3

  • 56

    Which of the following fixative can be used for electron microscopy? a. b. Glutaraldehyde c. d. Zenker’s fluid

    b. Glutaraldehyde

  • 57

    Stain of myelin:

    Luxol fast blue

  • 58

    Stain for spirochetes: a. Toluidine Blue b. Warthin-Starry c. Grocott Methanamine Silver d. Von Kossa’s Silver Nitrate

    b. Warthin-Starry

  • 59

    Expiration of license to operate of blood banks are after: a. 1 year b. 2 years c. January the next year d. anniversary date

    d. anniversary date

  • 60

    Best fixative for cytology: a. Ether alcohol b. Ethyl alcohol c. Formalin

    a. Ether alcohol

  • 61

    What type of autopsy is performed if the cause of death is unknown? a. Clinical autopsy b. Hospital autopsy c. Academic autopsy d. Forensic autopsy

    d. Forensic autopsy

  • 62

    Specimen for exfoliative cytology, except: a. Bronchial washing b. Urine c. Amniotic fluid d. Peritoneal fluid

    c. Amniotic fluid

  • 63

    The following substance are part of the 5-part drug panel, except: a. Phencyclidine b. Methamphetamine c. Tetra-hydrocannabinol d. Ethanol

    d. Ethanol

  • 64

    Which of the following acids are used to remove calcium ion deposits on tissues?

    Nitric Acid

  • 65

    What kind of quality control is important in maintaining long term accuracy of the analytical methods? a. Internal quality control b. External quality control c. Sensitivity d. Specificity

    b. External quality control

  • 66

    In statistics, this is used to determine whether there is a statistically significant difference between the standarddeviations of two groups of data. a. Mean b. Median c. F-test d. T-test

    c. F-test

  • 67

    It is a sample of known quantity with several analytes present a. Calibrator b. Reagent c. Standard d. Control

    d. Control

  • 68

    It is a sample of known quantity with several analytes present a. Calibrator b. Reagent c. Standard d. Control

    d. Control

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    Blood drop size in the manual wedge technique; a. 1 to 2 mm in diameter b. 2 to 3 mm in diameter c. 4 to 5 mm in diameter d. 5 to 6 mm in diameter

    b. 2 to 3 mm in diameter

  • 2

    In manual wedge technique, the pusher slide is held securely in the dominant hand at about: a. 15 to 20 degree angle b. 30 to 45 degree angle c. 45 to 50 degree angle d. 50 to 75 degree angle

    b. 30 to 45 degree angle

  • 3

    Counting area for the annual platelet count: a. 0.2 mm2 b. 1 mm2 c. 4 mm2 d. 0.4 mm2

    b. 1 mm2

  • 4

    For manual WBC count, after charging the hemocytometer, place it in a moist chamber for ___ minutes before counting the cells to give them time to settle: a. 5 minutes b. 10 minutes c. 15 minutes d. 30 minutes

    b. 10 minutes

  • 5

    Endomitosis occurs in megakaryocyte ____: a. Proliferation b. c. Maturation

    c. Maturation

  • 6

    Disorder characterized by presence of small platelets: a. Wiskott-Aldrich Syndrome b. May-Hegglin Anomaly c. Alport Syndrome d. Bernard-Soulier Syndrome

    a. Wiskott-Aldrich Syndrome

  • 7

    PDW measures: a. Average volume of platelet b. Average size of platelet c. Variation in platelet size d. Uniformity of platelet size

    d. Uniformity of platelet size

  • 8

    Measurement of MPV values should be based on specimens that are between ______: a. 1 to 4 hours b. 2 to 5 hours c. 3 to 6 hours d. 4 to 8 hours

    a. 1 to 4 hours

  • 9

    After 1 hour, an increase in MPV is expected by how many percent? a. 5% b. 10% c. 15% d. 20%

    d. 20%

  • 10

    INR recommended for patients undergoing treatment of deep venous thrombosis: a. 1-2 b. 2-3 c. 2.5-3.5 d. 3

    b. 2-3

  • 11

    Which of the following has the less risk for thrombosis? I. Geriatrics III. Children II. Neonates IV. Young adults a. I, III b. II, IV c. II, III d. I, IV

    c. II, III

  • 12

    One population of cells within the case; small cells predominant; nuclear shape is regular with an occasional cleft; chromatin pattern is homogenous with scanty cytoplasm and nucleoli are rarely visible: a. L1 b. L2 c. L3 d. L4

    a. L1

  • 13

    A medical technologist collected a sample from a patient, however it was short draw. Which of the following will be the effect on the patient’s haematocrit? a. No effect b. Increased c. Decreased

    c. Decreased

  • 14

    When the haematocrit is higher than normal, as in found in patients with polycythemia, the angle should be ___: a. 20 degree b. 30 degree c. 45 degree d. 50 degree

    a. 20 degree

  • 15

    Solid tumor counterpart of Acute Lymphoblastic Leukemia: a. Lymphoma, poorly differentiated b. Lymphoma, well differentiated c. Reticulum cell sarcoma d. Myeloma

    a. Lymphoma, poorly differentiated

  • 16

    Solid tumor counterpart of Plasma Cell Leukemia: a. Lymphoma, poorly differentiated b. Lymphoma, well differentiated c. Reticulum cell sarcoma d. Myeloma

    d. Myeloma

  • 17

    Examples of acquired coagulopathies: I. Pernicious anemia II. Glanzmann thrombasthenia III. Uremia IV. Bernard-Soulier syndrome a. I, III b. I, IV c. II, III d. II, IV

    a. I, III

  • 18

    ESR result of refrigerated sample not returned to room temperature: a. Decreased b. Increased c. No effect

    b. Increased

  • 19

    Components of heme portion of a hemoglobinmolecule: a. 1 iron and 1 pyrrole ring b. 4 iron and 1 pyrrole ring c. 4 iron and 4 pyrrole ring d. 1 iron and 4 pyrrole ring

    d. 1 iron and 4 pyrrole ring

  • 20

    Peripheral zone: I. Glycocalyx II. Sub-membranous area III. Plasma Membrane a. I only b. I, II c. II, III d. I, II, III

    d. I, II, III

  • 21

    Granules formed throughout the remaining maturation of eosinophils: a. Primary granules b. Secondary granules c. Lipid bodies d. Storage vesicles

    b. Secondary granules

  • 22

    Optical light scatter that correlates with cell volume and with internal complexity: I. Forward Light Scatter II. Forward Low Angle Light Scatter III. Forward High Angle Light Scatter IV. Orthogonal Light Scatter a. I, II b. II, III c. III, IV d. I, IV

    b. II, III

  • 23

    The following conditions are associated with normocytic RBCs, except: a. Aplastic anemia b. Hemolytic Anemia c. IDA d. Myelophthisic Anemia

    c. IDA

  • 24

    Stage of cell cycle that normally takes 4 hours: a. G1 b. S c. G2 d. Mitosis

    c. G2

  • 25

    Abnormal proliferation of both erythroid and granulocytic precursors; may include abnormal megakaryocytic and monocytic proliferations a. M4 b. M5 c. M6 d. M7

    c. M6

  • 26

    M6 is also known as? a. Acute Myelomonocytic Leukemia b. Acute Promyelocytic Leukemia c. Acute Erythroleukemia d. Acute Megakaryocytic Leukemia

    c. Acute Erythroleukemia

  • 27

    Who is regarded as the Father of Genetics? a. Anton van Leeuwenhoek b. Edward Jenner c. Gregor Mendel

    c. Gregor Mendel

  • 28

    Recipient of Nobel Prize for his discovery of the mechanism of antibody diversity: a. George Kohler & Cesar Milstein b. Gerald Edelman & Rodney Porter c. Susumu Tonegawa d. Rosalyn Yallow

    c. Susumu Tonegawa

  • 29

    Class II MHC molecules are recognized by which of the following? a. CD4+ T cells b. CD8+ T cells c. Natural killer cells d. Neutrophils

    a. CD4+ T cells

  • 30

    Anticoagulant used to collect blood samples for Direct Antiglobulin Test: a. Heparin b. EDTA c. Citrate d. Oxalate

    b. EDTA

  • 31

    The mot common cause of transfusion-related sepsis is: a. Whole blood b. Packed red cells c. Platelet concentrates d. Leukocyte concentrates

    c. Platelet concentrates

  • 32

    What should be done if a noticeable clot is found in an RBC unit? a. Issue the unit; the blood will be filtered b. Issue the unit; note the presence of clot on the release form c. Filter the unit in the blood bank before issue d. Do not issue the unit

    d. Do not issue the unit

  • 33

    Which of the following antigens are carried on a component of complement? a. Kx b. Lutheran c. Chido/Rodgers d. Gil

    c. Chido/Rodgers

  • 34

    Why is second infection of dengue considered as more severe than the first one?

    b. Because of the presence of more than one serotype

  • 35

    Antibodies to which of the following viral antigens are usually the first to be detected in HIV infection? a. gp120 b. gp160 c. gp41 d. p24

    d. p24

  • 36

    What test/s is not included in blood screening worldwide? a. HCV and HIV-1 b. HIV-2 c. CMV and HIV-2 d. Malaria

    c. CMV and HIV-2

  • 37

    What g is used to prepare pRBC directly from whole blood? a. 2300g b. 3000g c. 3200g d. 5000g

    d. 5000g

  • 38

    Donor deferral if patient is pregnant but had miscarriage within 4 months? a. Accept b. Defer for 6 weeks c. Defer for 6 months d. Defer for 12 months

    a. Accept

  • 39

    A donor has confessed that he had plasma products transfused because of past dengue infection. What is the deferral period for this situation? a. No deferral b. 12 months c. 1 year d. 6 months

    b. 12 months

  • 40

    Tumor marker for breast cancer with recurrence: a. ER/PR b. CEA c. CA 15-3 and CA 19-9 d. CYFRA

    c. CA 15-3

  • 41

    Which of the following autoantibodies indicates presence of systemic lupus? a. Anti-acetylcholine receptor b. Anti-Smith c. Anti-Scl 70 d. Anti-centromere

    b. Anti-Smith

  • 42

    Lack of CD4 and CD8 is characteristic of which of the following? a. Mature T cells b. Activated T cells c. d. Immature thymocytes

    d. Immature thymocytes

  • 43

    He proved that immunity to cowpox provided protection against smallpox, thus the mechanism of cross immunity: a. Mary Mallon b. Robert Koch c. Edward Jenner d. Edelman and Porter

    c. Edward Jenner

  • 44

    What is the corresponding Wiener nomenclature if the inherited gene is RO? a. Rh0 rh’hr’’ b. Rh0 hr’ hr’’ c. Rh0 hr’ rh’’ d. Rh0 rh’ rh’’

    b. Rh0 hr’ hr’’

  • 45

    What is the corresponding Fisher-Race nomenclature if the inherited gene is RO? a. DCe b. Dce c. DcE d. DCE

    b. Dce

  • 46

    Which blood group does Dolichos biflorus agglutinate? a. A1 b. B c. H d. D

    a. A1

  • 47

    The letter “T” in the acronym TORCH stands for? a. Trichenellosis b. Toxoplasmosis c. Treponema d. Trichiuris

    b. Toxoplasmosis

  • 48

    What is the pH of the skin? a. 5.2 b. 5.6 c. 7.2 d. 6.5

    b. 5.6

  • 49

    What is the minimum weight required if a male donor wants to undergo double RBC apheresis? a. > 110 lbs b. > 130 lbs c. > 150 lbs d. > 170 lbs

    b. > 130 lbs

  • 50

    What is the appropriate blood component to be given if a patient has Factor VIII deficiency? a. Washed RBC b. Fresh Frozen Plasma c. Cryoprecipitate d. Platelet concentrate

    c. Cryoprecipitate

  • 51

    What is the most common Lewis phenotype? a. Le (a-b-) b. Le (a+b-) c. Le (a-b+) d. Le (a+b+)

    c. Le (a-b+)

  • 52

    Most common blood group associated with severe delayed HTR: a. ABO b. Rh c. Lewis d. Kidd

    d. Kidd

  • 53

    Which of the following is a professional subject? a. Clinical Chemistry b. Physiology c. Biochemistry d. Anatomy

    a. Clinical Chemistry

  • 54

    All of the following are major subjects, except: a. Clinical Chemistry b. Clinical Microscopy c. Hematology d. Microbiology

    b. Clinical Microscopy

  • 55

    How many times can a person take the licensure exam before taking up refresher course? a. 1 b. 2 c. 3 d. 4

    c. 3

  • 56

    Which of the following fixative can be used for electron microscopy? a. b. Glutaraldehyde c. d. Zenker’s fluid

    b. Glutaraldehyde

  • 57

    Stain of myelin:

    Luxol fast blue

  • 58

    Stain for spirochetes: a. Toluidine Blue b. Warthin-Starry c. Grocott Methanamine Silver d. Von Kossa’s Silver Nitrate

    b. Warthin-Starry

  • 59

    Expiration of license to operate of blood banks are after: a. 1 year b. 2 years c. January the next year d. anniversary date

    d. anniversary date

  • 60

    Best fixative for cytology: a. Ether alcohol b. Ethyl alcohol c. Formalin

    a. Ether alcohol

  • 61

    What type of autopsy is performed if the cause of death is unknown? a. Clinical autopsy b. Hospital autopsy c. Academic autopsy d. Forensic autopsy

    d. Forensic autopsy

  • 62

    Specimen for exfoliative cytology, except: a. Bronchial washing b. Urine c. Amniotic fluid d. Peritoneal fluid

    c. Amniotic fluid

  • 63

    The following substance are part of the 5-part drug panel, except: a. Phencyclidine b. Methamphetamine c. Tetra-hydrocannabinol d. Ethanol

    d. Ethanol

  • 64

    Which of the following acids are used to remove calcium ion deposits on tissues?

    Nitric Acid

  • 65

    What kind of quality control is important in maintaining long term accuracy of the analytical methods? a. Internal quality control b. External quality control c. Sensitivity d. Specificity

    b. External quality control

  • 66

    In statistics, this is used to determine whether there is a statistically significant difference between the standarddeviations of two groups of data. a. Mean b. Median c. F-test d. T-test

    c. F-test

  • 67

    It is a sample of known quantity with several analytes present a. Calibrator b. Reagent c. Standard d. Control

    d. Control

  • 68

    It is a sample of known quantity with several analytes present a. Calibrator b. Reagent c. Standard d. Control

    d. Control